Nav: Home

Sexual minority cancer survivors face disparities in access to care and quality of life

May 20, 2019

Results from a study published early online in CANCER, a peer-reviewed journal of the American Cancer Society, point to the need for improved access to medical care for sexual minority cancer survivors, in particular female survivors. In female cancer survivors, poor access to care is more strongly related to poor quality of life among sexual minorities compared with heterosexuals.

Access to quality medical care is critical to the long-term health and well-being of cancer survivors. Evidence from non-cancer-related studies indicates that sexual minorities--including lesbian, gay, bisexual, or other non-heterosexual identified individuals--have worse access to care, but previous studies have not examined the issue among cancer survivors.

To assess sexual minority cancer survivors' access to care and their quality of life, Boston University School of Public Health's Ulrike Boehmer, PhD, and Jessica Gereige, MD, along with their colleagues, examined four years of Behavioral Risk Factor Surveillance Survey data on U.S. men and women who reported a history of cancer. Among the 70,524 cancer survivors, 1,931 identified themselves as sexual minorities.

"While we have extensive cancer surveillance in the U.S., sexual minority cancer survivors are excluded from surveillance, which means we have very limited information about this group. This study therefore provides much needed information about sexual minority cancer survivors," said Dr. Gereige.

Compared with heterosexual women, sexual minority women were more likely to report having no health insurance, being without a personal physician, avoiding medical care due to costs, and being without an annual medical visit. Among men, sexual minority men were more likely to avoid medical care due to costs, but men of all sexual orientations had similar access to care with respect to insurance status, having a personal physician, and annual visits.

Sexual minority women's access to care had a stronger association with three quality of life measures compared with heterosexual women. Specifically, deficits in access to care were linked with a greater likelihood of poor physical quality of life, poor mental quality of life, and difficulty concentrating among sexual minority women compared with heterosexual women. In men, deficits in access to care were linked with a higher likelihood of difficulty concentrating among sexual minorities than heterosexuals. Also, sexual minority status increased the likelihood of poor mental quality of life in men.

"Our study shows that sexual minority women suffer from poor access to care and that this is linked to worse quality of life. Since poor quality of life is linked to worse cancer survival rates, this calls for policy changes to improve access to care for sexual minority cancer survivors," said Dr. Boehmer. "The study's findings also point to an opportunity for clinicians to address difficulties in access to care with patients during treatment discussions, or at the completion of cancer therapy and during follow up visits. Clinicians who are aware of these disparities and address them during clinic visits may have an impact on sexual minority women's survival rates, which are lower than their heterosexual counterparts' rates."
-end-
Additional Information

NOTE: The information contained in this release is protected by copyright. Please include journal attribution in all coverage. A free abstract of this article will be available via the Cancer News Room upon online publication. For more information or to obtain a PDF of any study, please contact:

Penny Smith +44 (0) 1243 770448 (UK)
newsroom@wiley.com
Follow us on Twitter @WileyNews

Full Citation: "Cancer survivors' access to care and quality of life: Do sexual minorities fare worse than heterosexuals?" Ulrike Boehmer, Jessica Gereige, Michael Winter, and Al Ozonoff. CANCER; Published Online: May 20, 2019 (DOI: 10.1002/cncr.32151).

URL Upon Publication: http://doi.wiley.com/10.1002/cncr.32151

Author Contact: Meaghan Agnew, Boston University School of Public Health's Director of Editorial and Media Relations, at meaghans@bu.edu.

About the Journal

CANCER is a peer-reviewed publication of the American Cancer Society integrating scientific information from worldwide sources for all oncologic specialties. The objective of CANCER is to provide an interdisciplinary forum for the exchange of information among oncologic disciplines concerned with the etiology, course, and treatment of human cancer. CANCER is published on behalf of the American Cancer Society by Wiley and can be accessed online.

Follow us on Twitter @JournalCancer

About Wiley

Wiley is a global leader in research and education. Our online scientific, technical, medical, and scholarly journals, and our digital learning, assessment, certification and student-lifecycle services and solutions help universities, academic societies, businesses, governments and individuals to achieve their academic and professional goals. For more than 200 years, we have delivered consistent performance to our stakeholders. The Company's website can be accessed at http://www.wiley.com.

Wiley

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Teaching For Better Humans 2.0
More than test scores or good grades–what do kids need for the future? This hour, TED speakers explore how to help children grow into better humans, both during and after this time of crisis. Guests include educators Richard Culatta and Liz Kleinrock, psychologist Thomas Curran, and writer Jacqueline Woodson.
Now Playing: Science for the People

#556 The Power of Friendship
It's 2020 and times are tough. Maybe some of us are learning about social distancing the hard way. Maybe we just are all a little anxious. No matter what, we could probably use a friend. But what is a friend, exactly? And why do we need them so much? This week host Bethany Brookshire speaks with Lydia Denworth, author of the new book "Friendship: The Evolution, Biology, and Extraordinary Power of Life's Fundamental Bond". This episode is hosted by Bethany Brookshire, science writer from Science News.
Now Playing: Radiolab

Dispatch 3: Shared Immunity
More than a million people have caught Covid-19, and tens of thousands have died. But thousands more have survived and recovered. A week or so ago (aka, what feels like ten years in corona time) producer Molly Webster learned that many of those survivors possess a kind of superpower: antibodies trained to fight the virus. Not only that, they might be able to pass this power on to the people who are sick with corona, and still in the fight. Today we have the story of an experimental treatment that's popping up all over the country: convalescent plasma transfusion, a century-old procedure that some say may become one of our best weapons against this devastating, new disease.   If you have recovered from Covid-19 and want to donate plasma, national and local donation registries are gearing up to collect blood.  To sign up with the American Red Cross, a national organization that works in local communities, head here.  To find out more about the The National COVID-19 Convalescent Plasma Project, which we spoke about in our episode, including information on clinical trials or plasma donation projects in your community, go here.  And if you are in the greater New York City area, and want to donate convalescent plasma, head over to the New York Blood Center to sign up. Or, register with specific NYC hospitals here.   If you are sick with Covid-19, and are interested in participating in a clinical trial, or are looking for a plasma donor match, check in with your local hospital, university, or blood center for more; you can also find more information on trials at The National COVID-19 Convalescent Plasma Project. And lastly, Tatiana Prowell's tweet that tipped us off is here. This episode was reported by Molly Webster and produced by Pat Walters. Special thanks to Drs. Evan Bloch and Tim Byun, as well as the Albert Einstein College of Medicine.  Support Radiolab today at Radiolab.org/donate.